1. Home
  2. STBA vs NBTX Comparison

STBA vs NBTX Comparison

Compare STBA & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo S&T Bancorp Inc.

STBA

S&T Bancorp Inc.

HOLD

Current Price

$46.32

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$35.86

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STBA
NBTX
Founded
1902
2003
Country
United States
France
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
STBA
NBTX
Price
$46.32
$35.86
Analyst Decision
Hold
Strong Buy
Analyst Count
6
1
Target Price
$43.00
$36.00
AVG Volume (30 Days)
197.2K
53.7K
Earning Date
04-23-2026
03-31-2026
Dividend Yield
3.29%
N/A
EPS Growth
2.35
N/A
EPS
0.94
N/A
Revenue
N/A
N/A
Revenue This Year
$10.20
$58.17
Revenue Next Year
$4.14
N/A
P/E Ratio
$50.34
N/A
Revenue Growth
N/A
N/A
52 Week Low
$34.01
$4.46
52 Week High
$48.70
$57.14

Technical Indicators

Market Signals
Indicator
STBA
NBTX
Relative Strength Index (RSI) 55.14 44.87
Support Level $42.52 $30.15
Resistance Level N/A $41.89
Average True Range (ATR) 1.10 2.49
MACD 0.10 -0.29
Stochastic Oscillator 48.55 45.58

Price Performance

Historical Comparison
STBA
NBTX

About STBA S&T Bancorp Inc.

S&T Bancorp Inc is a financial holding company providing a full range of financial services to individuals and businesses in Pennsylvania and Ohio, including retail and commercial banking products, cash management, and trust and brokerage services. Through its subsidiary, it offers consumer, commercial, and small business banking services, including time and demand deposits, commercial and consumer loans, brokerage and trust services, and manages private investment accounts for individuals and institutions. The company earns revenue mainly from interest on loans and securities and fees for financial services, with net interest income as the principal source of revenue, and incurs expenses for deposits, funding sources, provision for credit losses, and operating costs.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: